124 related articles for article (PubMed ID: 6146391)
1. Effects of midazolam on directly stimulated muscle biopsies from control and malignant hyperthermia positive patients.
Fletcher JE; Rosenberg H; Hilf M
Can Anaesth Soc J; 1984 Jul; 31(4):377-81. PubMed ID: 6146391
[TBL] [Abstract][Full Text] [Related]
2. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
3. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
4. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
Ilias WK; Williams CH; Fulfer RT; Dozier SE
Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
[TBL] [Abstract][Full Text] [Related]
5. Age, fiber type composition and in vitro contracture responses in human malignant hyperthermia.
Ording H; Hansen U; Skovgaard LT
Acta Anaesthesiol Scand; 1988 Feb; 32(2):121-4. PubMed ID: 3348072
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs.
Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F
Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593
[TBL] [Abstract][Full Text] [Related]
7. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
McKenzie AJ; Couchman KG; Pollock N
Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
[TBL] [Abstract][Full Text] [Related]
8. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
9. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
Bendixen D; Ording H
Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
[TBL] [Abstract][Full Text] [Related]
10. Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Adnet PJ; Krivosic-Horber RM; Krivosic I; Haudecoeur G; Reyford HG; Adamantidis MM; Medahoui H
Br J Anaesth; 1994 Jan; 72(1):93-7. PubMed ID: 8110560
[TBL] [Abstract][Full Text] [Related]
11. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
Williams JH; Lee JC; Holland M
Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
[TBL] [Abstract][Full Text] [Related]
12. Halothane-caffeine contracture testing in neuromuscular diseases.
Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
[TBL] [Abstract][Full Text] [Related]
13. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
14. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
Foster PS; Denborough MA
Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
[TBL] [Abstract][Full Text] [Related]
15. Xenon does not induce contracture in human malignant hyperthermia muscle.
Baur CP; Klingler W; Jurkat-Rott K; Froeba G; Schoch E; Marx T; Georgieff M; Lehmann-Horn F
Br J Anaesth; 2000 Nov; 85(5):712-6. PubMed ID: 11094586
[TBL] [Abstract][Full Text] [Related]
16. Screening for malignant hyperthermia susceptibility.
Anderson IL; Rawstron RE; Dunlop DJ
N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
[TBL] [Abstract][Full Text] [Related]
17. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H
Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135
[TBL] [Abstract][Full Text] [Related]
18. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
[TBL] [Abstract][Full Text] [Related]
19. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
[TBL] [Abstract][Full Text] [Related]
20. Is resting membrane potential a possible indicator of viability of muscle bundles used in the in vitro caffeine contracture test?
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford HG; Dupuis BA
Anesth Analg; 1992 Jan; 74(1):105-11. PubMed ID: 1734769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
